Sansure Biotech Inc. (SHA:688289)
China · Delayed Price · Currency is CNY 15.50
-0.47 (-2.94%)
Oct 27, 2026, 3:00 PM CST
Sansure Biotech Market Cap
Sansure Biotech has a market cap or net worth of 8.81 billion as of October 27, 2026. It is the 8,448th most valuable company in the world and the 1,747th biggest in China. Its market cap has decreased by 30.67% in one year.
Market Cap
8.81B
Enterprise Value
6.59B
Revenue
1.61B
Global Rank
Country Rank
#1,747 China
PE Ratio
67.30
ChartMarket Cap Chart
Since August 28, 2020, Sansure Biotech's market cap has decreased from 46.42B to 8.81B, a decrease of -81.03%. That is a compound annual growth rate of -23.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2026 | 8.81B | -18.90% |
| Dec 31, 2025 | 10.86B | -16.48% |
| Dec 31, 2024 | 13.00B | 16.22% |
| Dec 29, 2023 | 11.19B | -12.24% |
| Dec 30, 2022 | 12.75B | -45.99% |
| Dec 31, 2021 | 23.60B | -48.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shenyang Xingqi Pharmaceutical | 11.80B |
| Tofflon Science and Technology Group | 10.23B |
| Jiangsu Hualan New Pharmaceutical Material | 10.16B |
| Autek China | 9.19B |
| Eyebright Medical Technology (Beijing) | 8.65B |
| Tinavi Medical Technologies | 7.57B |
| Mingyue Optical Lens | 7.44B |
| Aidite (Qinhuangdao) Technology | 6.84B |